HealthQuill Articles by: HealthQuill
Cordis, a US-based medical device maker, has acquired Switzerland’s MedAlliance for up to $1.1 billion to expand its product portfolio.
Health Medical Pharma

Cordis acquires medical device maker MedAlliance for $1.1 billion

HQ Team October 2, 2023: Cordis, a US-based medical device maker, has acquired Switzerland’s MedAlliance for up to $1.1 billion to expand its

Read More
A total of 770,875,433 (770.8 million) people globally have been infected by the coronavirus as of September 27 and 6,959,316 died due to the disease, according to the WHO.
Drugs Health Pharma

COVID-19 global death toll nears seven million, WHO says ‘still a threat’ 

HQ Team October 2, 2023: A total of 770,875,433 (770.8 million) people globally have been infected by the coronavirus as of September 27

Read More
A drug that mimics the benefits of rigorous exercise has been developed on mice by scientists at the University of Florida
Drugs Health Pharma

Weight-loss drug mimicking exercise may help treat obesity, diabetes

HQ Team October 2, 2023: A drug that mimics the benefits of rigorous exercise has been developed on mice by scientists at the

Read More
Walking more than five flights of stairs a day can cut the risk of heart disease by 20%, according to a study by researchers at the US-based Tulane University School of Public Health and Tropical Medicine.
Drugs Health Pharma

Take five flights of stairs daily to cut heart disease by 20%: Tulane study

HQ Team October 2, 2023: Walking more than five flights of stairs a day can cut the risk of heart disease by 20%,

Read More
Changing heat patterns are intensifying severe cyclones over the Eastern Arabian Sea affecting artisanal fishing livelihoods.
Climate Pharma

Warming upper ocean spawns severe storms over India’s west coast

HQ Team September 29, 2023: Changing heat patterns are intensifying severe cyclones over the Eastern Arabian Sea affecting artisanal fishing livelihoods. Weather systems

Read More
Pfizer announced the availability of its migraine management drug Rimegepant in Hong Kong — the company’s first market in Asia.
Drugs Health Pharma

Pfizer enters Hong Kong migraine market, its first in Asia

HQ Team September 29, 2023: Pfizer announced the availability of its migraine management drug Rimegepant in Hong Kong — the company’s first market

Read More
Bionomics Limited, a clinical-stage biotechnology company announced positive outcomes for its experimental drug to treat post-traumatic stress disorder (PTSD).
Drugs Health Pharma

Bionomics’ PTSD experimental drug yield positive results in trials

HQ Team September 29, 2023: Bionomics Limited, a clinical-stage biotechnology company announced positive outcomes for its experimental drug to treat post-traumatic stress disorder

Read More
DIOSynVax, a spin-out company of the University of Cambridge, is in its final stage of human trials of an antigen-based vaccine candidate to treat all coronaviruses.
Drugs Health Pharma

DIOSynVax to finish coronavirus vaccine trial in humans by month-end

HQ Team September 29, 2023: DIOSynVax, a spin-out company of the University of Cambridge, is in its final stage of human trials of

Read More
The USFDA has issued civil money penalties to 22 retailers selling illegal e-cigarettes and sought up to a maximum of $19,192 fine for a single violation from each retailer.
Drugs Health Pharma

USFDA imposes maximum fine on 22 retailers for selling illegal e-cigarettes

HQ Team September 29, 2023: The USFDA has issued civil money penalties to 22 retailers selling illegal e-cigarettes and sought up to a

Read More
Merck’s Biological Licence Application for a pulmonary arterial hypertension drug has been accepted for a priority review by the FDA.
Drugs Health Pharma

Merck gets priority review nod from USFDA for hypertension drug 

HQ Team September 28, 2023: Merck’s Biological Licence Application for a pulmonary arterial hypertension drug has been accepted for a priority review by

Read More